Central venous catheter-related bacteraemia is a substantial and preventable source of iatrogenic morbidity and mortality. A single episode of catheter-related bacteraemia has an estimated cost of A$50,000, with an attributable mortality between 10 and 35%. Catheter colonization is diagnosed with standard culture techniques. Diagnostic criteria for catheter-related bacteraemia include the results of cultures from the catheter tip, the peripheral blood and other possible sites of infection. The presence of clinical symptoms and subsequent defervescence may assist in making the diagnosis. This review explores the existing definitions of catheter-related infections and proposes a new and more rigorous classification with criteria for definite, probable and possible catheter-related bacteraemia. The authors hope that this classification will enhance the interpretation of the literature and the planning of new investigations.
INTRODUCTION AND EPIDEMIOLOGY
Central venous catheters (CVCs) are used throughout the developed world for the monitoring and therapy of critically ill patients. They are also commonly used for patients who require long-term venous access for parenteral nutrition, antimicrobial therapy and chemotherapy. Estimates of their use in the United States alone suggest that over 5 million CVCs are inserted annually 1, 2 . Although CVCs have significant benefits in many clinical situations, the increase in their use over the last 20 years has been associated with at least a doubling of resultant nosocomial bacteraemia 3, 4 .
Colonization of a CVC refers to the asymptomatic growth of organisms on the intravascular portion of the catheter. This appears to be a very common event, with a recent meta-analysis finding rates ranging between 14% and 71% for standard catheters 5 . More usual rates might be considered to be 15 to 40%, and Australian studies have reported colonization rates of 19 to 31% 6, 7 . While colonization has no direct adverse effects it is widely accepted as the harbinger of catheter-related bacteraemia, which is a much more serious nosocomial infection (see Pathogenesis). "Catheter-related bacteraemia" has been inconsistently defined in the literature, leading to difficulties in comparing studies and outcomes, and in defining appropriate management.
Central venous catheters are probably responsible for about 250,000 cases per year of nosocomial bacteraemia in the United States 8 , although some estimates are as high as 400,000 cases per year 9, 10 . The rates of catheter-related bacteraemia (CRB) vary between hospitals, clinical areas and patient groups. Rates as high as 30.2 per 1,000 catheter days have been reported for burns patients, compared with 2.1 per 1,000 catheter days for patients in respiratory intensive care units (ICUs) 11 . Overall estimates from Europe and the United States suggest that the usual incidence of CRB, as a percentage of catheters inserted, is somewhere between 3 and 7% 3 , although some studies have reported rates as high as 15% 9, 12, 13 . In a study of 15 Australian hospitals in the early 1990s it was reported that the incidence of CRB was 23 per 1,000 catheters purchased or 2.3% 14 . Bacteraemia was found to be far more likely to occur following insertion of a CVC compared to a peripheral venous catheter (Relative Risk [RR] 64; 95% confidence interval [CI] . Subsequent Australian studies have reported CRB rates of 4% 7, 15 .
Catheter-related bacteraemia is a serious nosocomial infection with substantial and directly attributable mortality and morbidity. Estimates of attributable mortality in the United States are 10 to 35% 2, 8, 9, [16] [17] [18] [19] . An Australian study reported an attributable mortality of 12% and suggested that the annual death rate in Australia as a direct result of intravascular catheter-associated sepsis exceeded that from AIDS 14 . In a matched case-control study, the additional financial cost attributable to an episode of CRB in critically ill patients has been calculated to be $U.S.28,690 per survivor 18, 20 . The survivors spend on average one extra week in ICU and an additional two to three weeks in hospital 18 .
The substantial human and financial costs of CVC related infections provide a strong motivation to explore and understand the aetiological factors of these infections. This becomes an even more compelling area for study when one considers the iatrogenic and preventable nature of the disease.
PATHOGENESIS OF CATHETER-RELATED INFECTIONS
There are two main mechanisms by which catheterrelated blood stream infection is thought to occur 2, 3, 9, [21] [22] [23] [24] [25] . The first, and most widely recognised, is colonization of the external surfaces of the catheter by organisms from the patient's skin around the insertion site. The second is contamination of the hub of one of the CVC lumens, with distal spread of the organisms down the intraluminal surface. Other possible mechanisms include haematogenous spread and seeding to the catheter tip, which occurs rarely if at all 1 , and contamination of fluid infusates, which is now much less common after some epidemics in the 1970s 2, 10 .
Colonization is accepted as an essential step in the pathogenesis of CRB, however most episodes of colonization do not progress to CRB, at least by the time of catheter removal 3 . The relationship between these two events is so strong that most definitions of CRB require a positive culture of the catheter tip as part of the diagnostic criteria. The Centres for Disease Control (CDC) definition of "catheterrelated blood stream infection" (CR-BSI) requires the "isolation of the same organism (i.e., identical species, antibiogram) from a semi-quantitative or quantitative culture of a catheter segment and from the blood (preferably drawn from a peripheral vein)" 2 . Colonization is a much more frequent event than CRB, and is therefore taken to be a necessary but not sufficient condition for the diagnosis of CRB.
Most studies have found a high level of concordance between microorganisms found on the skin at the insertion site and organisms subsequently found on the catheter tip 3, 26, 27 . Bacteria may contaminate the catheter tip at the time of insertion and subsequently cause CRB. In an intriguing study that examined catheter tips immediately after insertion, it was possible to show that 16% of distal catheter tips had already been contaminated on being driven through the skin of the insertion site 28 . Effective antisepsis in skin preparation of the insertion site 29 and full sterile barrier technique of catheter insertion 30, 31 have been shown to reduce subsequent CRB. In addition, it is supposed that bacteria contaminating the insertion site or subcutaneous tract after insertion will proliferate and migrate along the external surface of the catheter, along the subcutaneous catheter tract, and eventually reach the intravascular component of the catheter 3 . Subcutaneous spread of bacteria may be seen clinically as a "tract infection" of a tunnelled line, with associated inflammation and purulence, however it is usually an asymptomatic process 3 .
Raad et al 23 examined subcutaneous and intravascular catheter segments using electron microscopy and culture techniques. All CVCs were found to be subject to ultrastructural colonization and biofilm formation. The ultrastructural changes commenced as early as one day after catheter insertion. Even when semi-quantitative measures were used to grade individual catheters, by biofilm surface area or degree of colonization, there was no correlation with positive catheter-tip or blood cultures. However, it was found that intraluminal colonization increased progressively with time, and that "ultrastructural colonization and biofilm formation was predominantly intraluminal in the long-term CVC (>30 days)". External colonization and biofilm formation predominated in catheters that had been in place for <10 days, while internal colonization and biofilm formation "equalled or surpassed external colonization for catheters in place >30 days" 23 .
These observations raise several interesting possibilities. It is plausible that CRB is undiagnosed in some instances because catheter culture techniques are not adequate, and do not identify viable organisms within the biofilm. However, it seems evident that ultrastructural colonization of the catheter does not always lead to CRB. Raad et al hypothesized that the sessile bacteria in the biofilm became "planktonic" on their way to causing CRB, and that these bacteria were more likely to be detected by standard catheter-tip culture techniques 23 . In addition, the findings of progressively evolving intraluminal colonization suggest that there may be different mechanisms of pathogenesis at different stages in the catheter life. This supports the pathogenetic framework of an insertion site origin for early infections, and a hub site source for delayed infections.
During the early 1980s there were investigations into the rising frequency of coagulase negative staphylococcal bacteraemia in intensive care units and parenteral nutrition units 22, [32] [33] [34] . One identifiable source was the hub of the CVCs. Hub contamination was thought to occur during handling of the connections at catheter junctions, with some organisms isolated from catheter hubs also found on the hands of clinical staff. A subsequent surveillance study performed on CVCs in neonates found that 54% of cases of CRB were associated with contamination of the hub 35 . In two-thirds of the cases of CRB the responsible organism had been cultured from the hub prior to the episode of clinical sepsis. However, positive hub cultures were not strongly predictive of CRB, as 45% of the hub cultures were positive while the rate of CRB was only 23%. In addition, the identifiable organisms from a particular hub varied over time, and after having been culture positive, some of the hubs then became culture negative without any additional intervention. Candida species were isolated from 7 catheters, of which 5 (71%) went on to develop fungaemia, whereas only 17 of the 89 patients (19%) with hub cultures containing coagulase negative staphylococci developed CRB from the same species 35 .
The accumulated evidence supports a predominantly dual source model for CRB, which helps to identify different strategies for the prevention of this nosocomial infection 24 . The pathogenesis through skin organism contamination and external surface colonization identifies skin preparation, technical expertise, aseptic technique and dressings as critical areas. In addition, features that decrease line colonization and the formation of biofilm would be expected to be helpful. Hub contamination identifies the priorities of aseptic technique in handling line connections, sampling and injections. Contamination of infusates is now fortunately uncommon and does not usually lead to hub colonization, however the changing of administration sets may well be relevant, as well as the use of the catheter for particular products that may support bacterial growth, such as blood and lipid infusates 2 .
DEFINITIONS OF CATHETER-RELATED INFECTIONS
One of the major difficulties in reviewing the literature and designing new trials has been the diversity of terminology and definitions. Previous reviewers have called for a standardized set of definitions to be used 1, 36 . While the uniformity of approach is now improving there still remain significant areas of confusion. Two recent meta-analyses have emphasised the diversity of definitions in use 5, 37 . Detailed specification of the characteristics of catheter-related infection is an important step in developing further studies to advance this field 37 .
Centres for Disease Control Definitions
The CDC definition of catheter colonization is based upon reasonable laboratory criteria ( Table 1) 
Unfortunately, the identification of organisms from cultures of the catheter has also been variously described in the literature as "catheter contamination" 33, 38, 39 and "catheter infection" 7, 13, 15, 27, 33, 39, 40 . This has sometimes been clarified by the quantitative estimation of culture results, with some authors referring to a growth of less than 15 colony forming units (cfu) as contamination 39 . Even recent literature continues to confuse the terms colonization and catheter tip infection 7, 13, 15 . However, in keeping with the CDC definition, it has become increasingly well accepted practice to define a positive catheter culture with (15 cfu as catheter colonization. Although there are a range of culture techniques, the Maki roll-plate 41 and Sherertz sonication 42 techniques are the most commonly used semi-quantitative and quantitative techniques respectively 2 .
The CDC definitions of exit site infection and tunnel infection are entirely clinically based and relatively straightforward 2 . Unfortunately, the CDC definition of catheter-related blood stream infection (CR-BSI) is not as comprehensive as might be wished, particularly given the difficulties that arise in combining microbiological findings from various sites together with different clinical situations. It seems relatively straightforward that a positive catheter culture together with the same organism being identified on blood culture should be regarded as CR-BSI. However, in a recent meta-analysis of antisepticcoated catheters, Veenstra et al noted that "the majority of studies had no explicit requirements for the presence of clinical symptoms of blood-stream infection" 5 . Of the 13 studies considered suitable for analysis from a total of 215 articles, only one reported on clinical symptoms. Given the immunosuppressed state of many critically ill patients, the presence of bacteraemia may not always be associated with the clinical manifestations of the systemic inflammatory response syndrome (SIRS), severe sepsis (organ dysfunction), or septic shock (hypotension despite fluid resuscitation) 43 . In addition, many critically ill patients will have the continuation of those clinical syndromes associated with their initial diagnostic condition and other sequelae such as nosocomial pneumonia. This may make it impossible to detect clinical manifestations due to catheter-related infections, and also unreasonable to expect defervescence upon catheter removal. Therefore, the absence of the "accompanying clinical symptoms" of bacteraemia, or their subsequent defervescence after catheter removal, does not necessarily negate the microbiological finding of catheter-related bacteraemia. For these reasons, the term "catheter-related bacteraemia" (CRB) seems more precise, accurate and appropriate than catheter-related blood stream infection, catheter-related sepsis or catheter-related septicaemia.
Australian Infection Control Association Definitions
A different approach to standard definitions for "health-care related bloodstream infections" has been pursued by an expert working group of the Australian Infection Control Association (AICA), to assist in the national surveillance of nosocomial infection ( Table 2) 44 . Unfortunately, the proposed diagnostic criteria for establishing the presence of nosocomial bloodstream infection, of any aetiology, are Exit Site infection: erythema, tenderness, induration, or purulence within 2 cm of the skin at the exit site of the catheter.
Tunnel infection: eythema, tenderness, and induration in the tissues overlying the catheter and >2 cm from the exit site.
Catheter-related bloodstream infection (CR-BSI): isolation of the same organism (i.e., identical species, antibiogram) from a semiquantitative culture of a catheter segment and from the blood (preferably drawn from a peripheral vein) of a patient with accompanying clinical symptoms of BSI and no other apparent source of infection. In the absence of laboratory confirmation, defervescence after removal of an implicated catheter from a patient with BSI may be considered indirect evidence of CR-BSI. A bloodstream infection must meet one of the following criteria:
Criterion 1-for recognized pathogens Isolation of one (1) or more recognized bacterial or fungal pathogens from one (1) or more blood cultures (e.g., Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Klebsiella spp., Propteus spp., Salmonella spp., Candida albicans).
Criterion 2-for potential contaminants
The patient has at least one (1) of the following signs and symptoms within twenty-four (24) hours of a positive culture being collected:
• fever >38°C • chills • rigors • hypotension (systolic blood pressure 90 mmHg)
AND
There is isolation of a potential contaminant* from: (a) two (2) or more blood culture sets drawn on separate occasions within a five (5) day period (the organism must be identical) OR (b) a single blood culture set drawn from a patient with an intravascular device in situ (within forty-eight (48) hours of the episode), where: -either there was a resolution of the clinical signs and symptoms after removal of the device or following appropriate antimicrobial therapy -or an identical organism in significant quantity was isolated from the device or part thereof; e.g., catheter tip *Potential contaminants include the following: quite complex. They involve a distinction between "recognized pathogens", e.g., Staphylococcus aureus, E. coli, Candida albicans (Criterion 1) and "potential contaminants", e.g., diptheroids, propionibacteria (Criterion 2). Criterion 2 involves a variable number of positive cultures, and the detection and resolution of clinical signs and symptoms. However, the requirement for distinguishing between these two classes of organisms is less important for catheter-related infections, as less pathogenic bacteria are commonly responsible. This is recognized by the authors, and Criterion 2 is subsequently modified when an intravascular device is in situ. However, the simple confirmation of bloodstream infection is thereby rendered quite tortuous. Also, the signs and symptoms included are not the standard SIRS criteria, and the requirements for their presence or subsequent defervescence overlooks the potential anergy or established SIRS of the critically ill patient. Finally, the identification of organisms in "significant quantity" lacks precision, as discussed above.
The AICA definitions also specify criteria required to identify an intravascular device as the source of the bloodstream infection (Table 3) 44 . While these are very similar to the CDC definition of CR-BSI (Table 1) 2 , the AICA criteria also include situations when defervescence followed antibiotic therapy without line removal, or alternatively, when the same organism is isolated from an inflamed exit site. In both of these situations there is not a requirement to isolate the organism from the catheter tip. The AICA definition clearly facilitates the diagnosis when the line is left in situ, and antibiotic treatment is commenced, as may be practised in oncology and TPN patients with long-term tunnelled catheters. However, the diagnosis of CRB with the catheter in situ should really include additional techniques such as differential semi-quantitative cultures or cytospins 45, 46 . Furthermore, a response to antibiotics does not help to establish the primary site of infection, and while exit site cultures have been useful in establishing the pathogenesis of CRB, they have not been established as criteria for the diagnosis of CRB.
A New Definition and Classification of Catheter-Related Bacteraemia
As well as requiring the presence of clinical symptoms, the CDC definition of CR-BSI specifies that there should be "no other apparent source of infection". This is often overlooked in clinical studies. Veenstra et al 5 reported that "the majority of studies had no explicit requirements .... for the absence of other sources of infection". Of the 13 studies that they analysed, only three specified "no other sources of infection" as a criterion for the diagnosis of CR-BSI. While this may be implied but not specified in many studies, we believe that the diagnosis of definite CRB should explicitly require the absence of any other positive cultures of the same organism from other sites ( Table 4 and 5).
The likelihood of detecting organisms at "other apparent sources" is strongly related to the frequency with which cultures from additional sites are taken. Many ICUs take regular scheduled surveillance cultures from various sites without specific clinical indications, which will produce positive culture results on occasions. Although molecular biological techniques now offer the ability to confirm that the organisms are indeed identical, this will not resolve 479 
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While device type/procedure should be specified in all bloodstream infections, the specified criteria by which to diagnose an intravascular device-associated infection are as follows:
• No other apparent primary focus for infection AND • Intravascular access device is present within 48 hours of the event AND • EITHER isolation of identical organism from appropriate quantitative cultures of the device or part thereof (e.g., catheter tip) • OR resolution of clinical signs and symptoms of infection after removal of the device and/or following appropriate antibiotic therapy • OR isolation of identical organism(s) from the exit site in the setting of purulent discharge or painful erythema at the exit site, or along the tunnel, if such exists.
TABLE 4 A new definition and classification for catheter-related bacteraemia
Definite Catheter-Related Bacteraemia (CRB): A colonized catheter, bacteraemia with the same organism, and the organism not identified at any other site that is a possible source of the bacteraemia.
Probable CRB:
Type 1-A colonized catheter, bacteraemia with the same organism, catheter the most likely source of bacteraemia, although the same organism has been identified and is colonizing another site. Type 2-A colonized catheter, clinical manifestions of sepsis, defervescence after removal of implicated catheter, however no laboratory confirmation of bacteraemia. the difficulties of clinical interpretation. For instance, in circumstances where a patient has a positive tracheal aspirate culture with an organism that is identical to the catheter tip and blood culture results, the clinician is required to judge whether a nosocomial pneumonia is present, or if this represents only colonization of the lower respiratory tract. If nosocomial pneumonia is not present then how does the colonization of the respiratory tract with the same organism impact upon the diagnosis of CRB? If the clinical investigator regards this as another "apparent source" and therefore rejects the diagnosis of CRB, then what reassurance is there that other centres have been performing similar surveillance cultures and are as conservative in interpreting their results?
We would suggest that the situation of a matching catheter tip and blood cultures, with an additional site that was considered colonized with the same organism when the catheter was in situ, should be classified as "probable CRB-type 1" (Table 4 and 5) . Clearly, if there was considered to be active infection, rather than colonization, with the same organism at these sites, then this precludes the diagnosis of CRB.
Ironically, the CDC definition of CR-BSI stipulates that "In the absence of laboratory confirmation, defervescence after removal of an implicated catheter from a patient with BSI may be considered indirect evidence of CR-BSI" 2 . It is unclear from the definition whether the absent laboratory confirmation refers to the blood culture, the catheter tip, or possibly both. Similarly, "absent" might variously be interpreted as the culture could not be performed, the specimen was lost, or the result was in fact negative. Hopefully, these would be fairly rare events, and a lost specimen or result would always be presumed to be negative. However, the methods for culturing catheter segments do have modestly limited sensitivities of 70 to 80% and hence a real "false negative" can occur 23, 42, 47 . In this situation clinical defervescence following the removal of the catheter clearly has increased importance as a means of attempting to identify the catheter as the source of infection. However, the interpretation of clinical symptoms may be difficult, as we have detailed above, and defervescence could be due to other factors such as commencement of antibiotics, changing a urinary catheter, or the resolution of some other infection. If the catheter tip culture has not been performed or is negative, and if infection or colonization at another site is present, then this would seem to preclude identifying the catheter as the source of the bacteraemia. We would suggest that when defervescence on catheter removal occurs together with a positive blood culture, in the absence of a positive catheter tip culture and having established that other possible sources of infection are culture negative, then this scenario is more appropriately considered "possible CRB" (Tables 4 and 5 ).
We would maintain that the case for CRB is actually more compelling in the reverse situation, where the catheter culture is positive, an appropriate clinical syndrome existed with defervescence on catheter removal, but the contemporaneous blood culture was negative or missing. Given the potentially intermittent nature of bacteraemia it would not be surprising for a single set of cultures to be negative. These could then be considered criteria for the diagnosis of "probable CRB-type 2" (Tables 4 and 5 ). In this situation the clinical symptoms of infection, and subsequent defervescence on catheter removal, are required to establish the distinction between probable CRB and simple catheter colonization.
On occasions, additional and more sophisticated definitions of a common problem may further obscure clarity in interpretation of the literature and research. In order to facilitate analysis of previous work it is important to note that the combination of the two groups of "definite" and "possible" CRB constitute the same group as the CDC and AICIA definitions for CR-BSI 2,44 . We have attempted to provide more precise and appropriate definitions for the 480 D. J. FRAENKEL, C. RICKARD, J. LIPMAN Anaesthesia and Intensive Care, Vol. 28, No. 5, October 2000 
THE COMPONENT PARTS OF THE PROBLEM AND MEANS OF PREVENTION Site Selection
The choice of catheter insertion sites, relative and absolute contraindications to their use, and the associated incidence of adverse events are frequently contentious issues. However, there is a reasonable body of evidence that identifies differing infection rates for the commonly used insertion sites.
An Australian study by Collignon et al found that the subclavian site had a significantly lower incidence of colonization (15%) than the internal jugular (28%) site 6 . There are many other studies that have demonstrated the presence of a higher colonization rate associated with the internal jugular site 7, 39, 48 . This appears to be a consistent finding in most studies of adequate design and power, and remains a significant variable even with the use of antimicrobial-coated catheters 47, 49, 50 . The internal jugular site is more difficult to sterilize and keep aseptic during insertion, maintenance of appropriate dressings is difficult, the skin temperature is higher and the site is subject to additional movement and frequent contamination from oropharyngeal secretions 7, 48, 51, 52 .
Comparisons of subclavian and femoral insertion sites have established that the femoral site also has an increased rate of catheter colonization. Collignon et al 6 found a 34% incidence of colonization and Goetz et al 38 found a hazard ratio of 4.2 (CI 2.0-8.8: P=0.0001) for the femoral site. The study by Williams et al 53 purporting to establish the safety of the femoral technique studied only 150 catheters and has serious methodological flaws. In a multivariate analysis, as part of a study of a coated catheter, Raad et al found insertion of a catheter into the subclavian vein was a significant and independent protective factor compared to the femoral vein and to the internal jugular vein 50 . Darouiche et al in an even larger study of coated catheters found the odds ratio for catheter colonization following insertion of the catheter into the femoral or jugular vein to be 3.05 (CI 1.86-5.01; P<0.001) 47 .
Factors other than infection rates, including operator experience and the risk of complications such as bleeding and pneumothorax, may influence the preferred insertion site in any given clinical situation. However, there seems to be adequate evidence to indicate that the subclavian site should be the preferred insertion site in otherwise uncomplicated patients.
Subcutaneous Tunnelling of Catheters
The creation of a deliberately lengthened subcutaneous tract during catheter insertion has been practised to try to reduce CRB, although this manoeuvre has never achieved widespread popularity 3 . The increased distance between insertion site and catheter tip has been considered to reduce the likelihood that colonization of the subcutaneous segment of the catheter will progress on to colonization of the catheter tip and eventually CRB 52 . Whether the colonization rate would be reduced or simply delayed by the longer tract is uncertain.
A recent meta-analysis of tunnelled catheters found a reduction in colonization of 39% (RR 0.61; CI 0.39-0.95) and a reduction in CRB of 44% (RR 0.56; CI 0.31-1.0) 52 . However, the decrease in CRB was due to the inclusion of a single trial of tunnelling at the internal jugular site. No significant benefit was seen for the pooled results of the trials involving the subclavian site (RR 0.71; CI 0.36-1.43) 52 .
A recent study of tunnelled femoral catheters 54 reported the frequency of CR-BSI and "probable systemic catheter-related sepsis", the latter corresponding to probable CRB type 2 in our proposed classification. Although the incidence and time to CRB were not altered by tunnelling of the catheters, the rates of catheter colonization and probable CRB were reduced 54 .
The jugular and femoral sites exhibit increased temperature, bacterial colonization and contamination, and may demonstrate a benefit from tunnelling of the catheter. However, current evidence does not support the routine use of tunnelled catheters 51 .
Clinical Expertise
As with many other procedures it is recognized that during the training phase of CVC insertion there may be a higher rate of complications 53, 55 . This can be expected to include a higher rate of infection, reflecting multiple needle passes and inadvertent breaches in sterile technique. The use of the Seldinger technique poses particular hazards for sterile technique. Novice operators may not pay adequate attention to the wide arc of the guide wire and the subsequent need to control its free end, as well as to ensure adequate draping well beyond its radius. Breaches in sterile technique are also more likely during procedures conducted during emergencies 38 .
Educational programs for clinical staff result in improved care and reduced site colonization of intravascular catheters 56 . Correspondingly, the lack of compliance with written guidelines has been demonstrated to independently increase the risk of catheter-related infections by a factor of five 57 . The patient-tonurse ratio and the number of nursing hours were identified as independent risk factors for CRB during a protracted outbreak of infection in a North American surgical ICU 58 . This was a carefully performed case-control study that controlled for multiple confounding factors. An increase in the patient-nurse ratio from 1 to 2 produced an adjusted odds ration of 61.5 (CI 1.23-3074) for CRB 58 . These are important and cost-effective issues to address, in view of the mortality and treatment costs of an episode of CRB 59 .
Skin Preparation
As previously remarked upon, there is a strong association between the level of colonization of the skin at the insertion site and the rate of subsequent catheter colonization and CRB 3 . It is therefore important to consider the means of antisepsis of the chosen insertion site. The landmark study in this area was conducted by Maki et al and compared 2% aqueous chlorhexidine, 10% povidone-iodine and 70% alcohol 29 . They found the lowest incidence of catheter colonization and CRB using the chlorhexidine skin preparation. Interestingly, considering the wide impact of this study, 75% of the catheters studied were actually arterial catheters, and the central venous catheters were not inserted using full barrier precautions. The use of an aqueous preparation of 2% chlorhexidine gluconate ("Hibiprep", Stuart, U.S.A.) in this study apparently reflected a lack of familiarity and availability of chlorhexidine in North America at the time (J. Faoagali, personal communication). Preparations of 2% chlorhexidine in alcohol should be considered to be at least as efficacious.
Sterile Technique
Surprisingly, it was really not until the 1980s that infection control issues concerning invasive procedures were widely addressed 60 . Once it was understood that disinfection and contamination of the site of the procedure were important determinants of catheter colonization, then the standard of aseptic technique during catheter insertion was an area for active investigation.
Historically, many CVCs had been inserted in the operating theatre environment for intra-operative use, with washed or gloved hands and minimal draping of the field. Some centres reported their caseseries audit work around the time of introducing full sterile technique and/or full barrier draping. Reductions of around 50% in catheter colonization rates were reported 31 . In a prospective controlled trial of the maximal sterile barrier (MSB-mask/cap/ sterile gloves/gown/large drape) compared with control precautions (sterile gloves and small drape only) there was a significant 75% reduction in line colonization 30 . The rate of CRB was 6.3 times higher in the control group (P=0.06). The cumulative risk of CRB by duration of catheterization was significantly improved for the MSB group on a Kaplan-Meier analysis 30 . The accompanying editorial concluded "Maximal barriers … are inexpensive and highly cost effective, and now should be considered the standard of care for insertion of central venous devices of all types" 60 .
Dressings
High levels of colonization of the insertion site correlate with increased frequency of catheter colonization and CRB 3 . Therefore, any dressing over an insertion site that promotes bacterial growth might be presumed to increase infection rates. This became an active area for investigation following the advent of transparent self-adhesive polyurethane dressings, which by trapping moisture under the dressing were likely to increase levels of insertion site colonization.
In an important study of 442 pulmonary artery catheters, patients were randomized to receive a dressing of sterile gauze and tape (replaced every 2 days), a conventional polyurethane dressing (replaced every 5 days), or a highly permeable polyurethane dressing (replaced every 5 days) 61 . Skin colonization at the time of catheter removal was lowest for the gauze dressing (101.3 cfu), intermediate for the permeable polyurethane dressing (101.8 cfu), and highest for the conventional polyurethane dressing ( 102.0 cfu). However, there were no significant differences in catheter colonization or CRB between the groups 61 .
Current CDC guidelines do not suggest any particular dressing material be used, nor any particular frequency for routine replacement of the dressings other than to replace the dressing when it "becomes damp, loosened, or soiled" 2 . However, the permeable polyurethane dressings allow continuous observation of the insertion site, do not become saturated with respiratory or other body fluids, and help to stabilize and secure the catheter. For these reasons, permeable polyurethane dressings may be considered preferable to gauze dressings.
Duration of Catheters and Scheduled Replacement
One of the most consistent findings in studies of CRB is that the incidence increases with the duration in situ of the catheter 2, 3, 6, 9, 26, 27, 48, 61, 62 . This phenomenon is consistent with the mechanisms for the pathogenesis of CRB described above. Both the external colonization of the line by skin organisms and the internal colonization following hub contamination could reasonably be assumed to have a time-dependent component 23 .
In view of the ongoing risk of CRB following CVC placement, it is important to continually review the need for central venous access in individual patients. The best means of prevention may be the early removal of the CVC as soon as peripheral access becomes appropriate and feasible. Early line removal is an effective and very cost-efficient way of removing the risk of CRB.
The practice of routinely changing catheters according to some defined time period to reduce the risk of CRB is commonly referred to as "scheduled" replacement. There is little or no support from the literature for scheduled replacement, even though it continues to be a common clinical practice. Cook et al 37 looked at the evidence for scheduled replacement using guide-wire exchanges and/or new site replacements. They found no evidence that scheduled replacement, using either of the replacement techniques, at 3 days or 7 days had any advantage over a replacement based on clinical indications. Studies by Cobb et al 63 and Bock et al 64 found that in the patients who received new site replacements there was no difference between scheduled replacement every three days or replacements on clinical indications. Uldall et al 65 studied patients with subclavian haemodialysis catheters and found that the CRB incidence was the same in seven-day scheduled and clinically indicated replacement groups.
It may seem contradictory that the incidence of CRB is related to CVC duration, but that scheduled replacement confers no benefit. However, as suggested previously (Section 2), early catheter colonization and CRB may be due to contamination of the CVC or site at the time of insertion. In this instance, while catheter tip colonization and CRB may increase with CVC duration, repeated insertion of replacement CVCs will not necessarily confer any benefit, and may even increase the infection rate. Eyer et al 66 actually found the lowest rate of catheter colonization occurred with clinical indications for replacement using a new site when required, compared with seven -day scheduled changes using either a new site or guide-wire exchange.
Guide-Wire Exchanges
Another controversial issue in CVC management has been the role of guide-wire exchanges, where an existing catheter is cannulated with a guide-wire, the old catheter removed over it, and a new catheter inserted over the guide-wire through the old insertion tract. This practice is uncommon in Australia and New Zealand, but apparently widespread in North America.
There have been a number of studies of guide-wire exchanges of varying quality, and these are well summarized in a systematic review of the literature by Cook et al 37 . There were trends towards higher rates of catheter colonization, catheter exit-site infection and CRB in association with the practice of guidewire exchanges. Not surprisingly, there was a trend towards reduced incidence of mechanical complications from catheter insertion using a guide-wire exchange technique. The authors concluded, "guidewire exchange of central venous catheters may be associated with a greater risk of catheterrelated infection . … If guide-wire exchange is used, meticulous aseptic technique is necessary" 37 .
In practical terms the technique of guide-wire exchange precludes aseptic technique. Even with the precautions of plentiful antiseptic and changing trays and drapes between catheter removal and insertion, it clearly remains impossible to disinfect the subcutaneous tract of the original line. In addition, there is no assurance that the external portion of the guidewire is sterilized by the subsequent topical application of antiseptics, while the subcutaneous and intravascular portions of the guide-wire remain contaminated from contact with the previous catheter and then the subcutaneous tract.
One well controlled and widely quoted study revealed that patients in the guide-wire exchange group were more likely to have CRB after 72 hours of catheterization (6% vs 0%, P=0.06) 63 . However, replacements at new sites were associated with a 5% mechanical complication rate, compared with 1% for the guide-wire exchange group. The authors concluded that "exchanging catheters with the use of a guide-wire increases the risk of bloodstream infection, but replacement involving insertion of catheters at new sites increases the risk of mechanical complications". Reviewers frequently misinterpret these conclusions as support for the practise of guide-wire exchange. Such an interpretation would presume at least an equivalence in attributable morbidity and mortality between a 6% incidence of CRB and a 4% difference in the rate of mechanical complications. This would seem unlikely as, while vascular injury or pneumothorax can of course be life-threatening, these catheter-related complications are usually quite benign compared to the 10 to 35% attributable mortality of an episode of CRB 2, 8, 19 . Therefore, the possible increase in CRB rates commented on by Cook et al with guide-wire exchanges (RR 1.72; CI 0.89-3.33) would seem likely to outweigh any probable benefits from possibly reduced mechanical complications (RR 0.51; CI 0.20-1.32) 37 .
Administration Set and Fluid Changes
In the early 1970s manufacturer-contaminated intravenous fluid was responsible for an epidemic of CRB 2 . At this time fluid administration sets were recognized as a potential area of bacterial growth, following contamination from the intravenous (IV) fluid or from the catheter. Previously, sets had been used until the catheter was removed or until the set malfunctioned. Subsequently, it became routine practice to change the administration set and connectors on a daily basis, in the belief that this would reduce the incidence of CRB 2,67 .
However, in the following years it became apparent that the incidence of infection due to contaminated IV fluids was actually quite low, and the practice of daily routine set replacement was rescrutinized 2,34,68 . The potential for savings in disposable supplies and nursing resources prompted the comparison of daily and 48 hourly set changes 67, 69 , which established equal or reduced infection rates in the 48 hour group. This was followed by further studies looking at 72 hour [70] [71] [72] [73] and 96 hour 34 changes with similar results.
While the current CDC recommendation is that set changes should occur "no more frequently than at 72-hour intervals, unless clinically indicated" 2 , the optimum frequency is not known. As hub contamination is an important cause of CRB 33 , it is possible that even less frequent changes would reduce the risk of hub colonization, by decreasing the incidence of improper sterile technique in accessing the catheter and preparing or changing the administration set.
Routine 24-hour changes of intravenous fluid solutions were also implemented in the early 1970s and still continue today 2 . The CDC regards this as an "unresolved issue". While blood products and lipid emulsions are more likely to sustain bacterial growth in vitro, there is limited data to support current practices. The CDC recommends 24-hour set and fluid changes for lipid-mix infusions, such as 3-in-1 TPN, and completion of infusions of lipid-only products within 12 hours 2 .
Catheter Materials
The earliest investigations of the impact of CVC technology on catheter colonization and CRB examined the differing plastic compounds used in catheter construction. Studies of peripheral venous catheters had established that bacteria adhered least well to siliconized steel needles, followed by Teflon™ catheters, and adhered best to polyethylene catheters 74 . Hydrophobic bacteria including S. aureus were found to be less likely to adhere to the hydrophobic surfaces of silicon or Teflon™, particularly when fibrin or biofilms were present on the catheter. A similar study found that polyvinyl chloride catheters were colonized more frequently than Teflon™ catheters 75 .
A study comparing polyurethane and polyethylene long line CVCs found that the use of polyurethane significantly reduced the incidence of clinical thrombophlebitis and improved the catheter's structural characteristics 76 . In a randomized controlled trial of peripheral venous catheters, Maki et al 77 established that polyurethane catheters had the same low infection rate as Teflon™, but with a lower incidence of phlebitis. The polyurethane had a smoother microsurface and was more flexible than Teflon™ at body temperature. Another study of peripheral venous catheters demonstrated a 46% reduction in thrombophlebitis with the use of polyurethane catheters compared with Teflon™ 78 . Polyurethane has higher tensile strength and is less thrombogenic than silicone 79 . Catheters are now commonly made of pliable non-deforming polyurethane with decreased plasticizer content, and the extrusion of polymers under high temperature control results in ultra-smooth surfaces 79, 80 .
Antimicrobial Catheters
Over the past decade there has been increasing interest in modifications to central venous catheters that confer specific antimicrobial properties 21, [81] [82] [83] . Catheters were initially heparin coated in an effort to reduce biofilm formation and bacterial adherence 84 . Subsequently, the external surfaces of catheters have been coated with a range of antimicrobial substances, and these are now also being applied to the internal luminal surfaces 9 . Most recently catheters have been produced which are made from polymers permeated with antimicrobial substances.
Thrombus formation on the intravascular portion of the catheter, on either external or internal surfaces, or within the surrounding vessel is a risk factor for catheter colonization and subsequent bacteraemia. Heparin bonding of pulmonary artery catheters has been shown to reduce the incidence of catheter clot formation within the first 24 hours 84 . Unfortunately, benzalkonium heparin bonded catheters lose their in vitro antimicrobial activity in the first few days, and their bonded heparin is lost in vivo in the first few hours after insertion 84 . A method of covalent bonding of partially depolymerized heparin to polyurethane catheters may offer reduced incidence of catheter colonization and bacteraemia 85 .
An early approach to developing an antimicrobial catheter was the attachable silver impregnated cuff. This could be placed around the line and was positioned at least 0.25 to 0.75 cm below the skin surface 86 . The silver impregnated cuff reduced colonization by a factor of three, from 29% to 9% (P=0.002), and CRB by a factor of four, 3.7% to 1.0% (P=0.12). However, positioning and subsequent extrusion of the cuffs was a technical problem, and further studies with longer catheter durations, beyond the mean of nine days from this initial study, failed to show any benefit from the cuff 87 . The attachable cuff was constructed from biodegradable collagen to which the silver was chelated. One explanation for the lack of efficacy of this approach was that the collagen was absorbed over the first week, after which there was no further antimicrobial action.
Chlorhexidine and Silver Sulphadiazine Catheters
The most extensively trialed of the antimicrobial catheter designs is coated externally with chlorhexidine gluconate and silver sulphadiazine (CSS) ("Arrowgard", Arrow International, Reading, PA). Silver ions are thought to have their antimicrobial activity by binding to the DNA helix in organisms and interfering with replication. Chlorhexidine has a broad spectrum of action against bacteria and yeasts, and resistance is rare and associated with the use of dilute aqueous solutions. It alters the cell membrane of organisms and therefore facilitates penetration of silver ions into the cell. Chlorhexidine and silver sulfadiazine have been demonstrated to have a synergistic effect.
Initial acceptance of this catheter was impeded by the lack of supportive clinical literature, other than an abstract by Maki in 1991 88 . However, Maki et al 8 have now published a well conducted randomized controlled clinical trial in which the antiseptic coated catheters were half as likely to be colonized (RR 0.56; CI 0.36-0.89) and five times less likely to cause CRB (RR 0.21; CI 0.03-0.95). Both of the cases of CRB in the antiseptic catheter group were associated with contamination of the catheter hub in catheters that had been replaced over a guide-wire. It is interesting to note that eight out of the 11 catheters that caused CRB, both antiseptic coated (2 of 2) and controls (6 of 9), had been inserted by guide-wire exchange, while this technique had been used overall on only approximately 50% of the catheters. The microbiological isolates from both groups were examined and none of them showed in vitro resistance to chlorhexidine or silver sulphadiazine. Surface antimicrobial activity could be demonstrated on the antiseptic coated catheters up to 15 days after insertion, although the extent and effectiveness of this late activity was not described 8 .
Other studies have reported less convincing or negative results. Some of these studies are surprisingly small and hence underpowered 89, 90 while others examined catheters with exceptionally long durations in situ that were not even removed upon a presumptive diagnosis of CRB 91 . Fortunately, a recently published meta-analysis has examined data from 11 out of 12 randomized trials evaluating the efficacy of CSS catheters 5 . The authors found a significant decrease in CRB using the CSS catheters, with a summary odds ratio for CSS catheter colonization of 0.44 (CI 0.36-0.54; P<0.001) and for CRB of 0.56 (CI 0.37-0.84; P=0.005).
The adverse effects of the CSS catheters have been relatively limited. Erythema at the insertion site has been significantly increased, although overall scores for inflammation may not be raised 8 . There have been no reports of acquired resistance to the disinfectants used. There are, however, two case reports of anaphylaxis following central venous catheter insertion, which were probably attributable to the chlorhexidine in the catheter coating 92, 93 . While this is obviously a very rare event, it may also be difficult to recognise in the polypharmaceutical environment of intensive care or anaesthesia.
Rifampicin and Minocycline Catheters
The antibiotic combination of rifampicin and minocycline (RM), coated onto the external and internal surfaces of the catheter, has also been well studied 94, 95 . Resistance studies of staphylococcal isolates from episodes of CRB 94 and in vitro studies of RM coated polyurethane catheters demonstrated synergistic activity against slime-producing strains of S. aureus and S. epidermidis, Enterococcus faecalis, gram-negative bacilli and Candida albicans 95 . The RM combination was more efficacious against grampositive cocci than vancomycin, and activity against C. albicans was comparable with catheters coated with amphotericin B. In vitro and in vivo animal model comparisons with the CSS catheter suggested that the RM catheters were more effective in preventing colonization with S. aureus and that the inhibitory activity was of longer duration 96 . Subsequent in vitro work has also suggested that the RM catheters demonstrate greater zones of inhibition for a longer duration than the CSS catheters 97 .
In a prospective randomized controlled clinical trial Raad et al 50 compared uncoated and RM catheters, and reported a significant decrease in positive catheter tip cultures from 26% to 8%. There was a 5% CRB rate in uncoated catheters but no episode of CRB using the RM catheter. There was no evidence of resistance to rifampicin or minocycline amongst the organisms cultured during the study 50 .
Raad et al 98 subsequently assessed the colonization and antimicrobial activity of RM catheters following their removal. They utilized semi-quantitative scanning electron microscopy, high-performance liquid chromatography and culture techniques. Although they reported significantly reduced ultrastructural colonization of the RM lines, it is interesting that mild-to-heavy ultrastructural colonization was still detected on 35% of the coated catheters. Antimicrobial activity against S. epidermidis was maintained for up to 16 days, and the presence of rifampicin and minocycline could still be detected on the catheters up to 14 days.
Comparison of Antimicrobial Catheters
These two types of carefully developed and studied antimicrobial catheters were compared in a prospective randomized controlled trial 47 . This multicentre trial found that the RM catheter was one third as likely as the CSS catheter to be colonized (7.9% vs 22.8%) and one twelfth as likely to be the cause of CRB (0.3% vs 3.4%). Importantly, all catheters were inserted through a new percutaneous site (cf guidewire exchange) and the laboratory techniques included roll-plate and sonication cultures of the catheter tips 41, 42 . Typing and sensitivity testing of cultured organisms was rigorous. Of some concern was the failure to analyse on an intention-to-treat basis, and the high colonization rate of the CSS catheters, compared with other previous studies. In addition there were no defined indications for removal of the catheters and a blood culture was not always taken at the time of catheter removal, which may allow the introduction of additional elements of bias in a non-blinded study 47 .
It is interesting that 12 of the 14 episodes of CRB in this study occurred after the catheter had been in situ for more than seven days-the only case of CRB for the RM catheters and 11 out of 13 cases for the CSS catheters 47 . The authors attributed the reduction in catheter colonization and CRB using the RM catheters to the choice of antimicrobials and the coating having been applied to both the external and internal surfaces. However, the internal coating of the catheter may have been less important than the duration of activity of the antimicrobial coating. Only 12% of all the catheters remained in situ at 15 days, and 5% at 20 days. The catheters associated with CRB had a median duration of 11 days. As previously established by Raad et al 23 external colonization and biofilm formation predominates in catheters for at least the first 10 days, and internal colonization becomes predominant only after 30 days. So the catheters probably were not in situ for long enough for internal colonization to become a major pathogenic factor. However, there is evidence that the RM coating has a longevity of up to 14 days, while that of the CSS catheter may be less than a week 96, 97, 99 . The duration of antimicrobial activity may therefore be a more important factor than the distribution of the coating in the first 2 to 3 weeks of catheter use.
If the cost benefits of antimicrobial catheters are to be fully realised then it becomes increasingly important that catheters can be left in situ for long periods of time in the absence of clinical suspicion of CRB. As well as improving the longevity of the catheter itself, there is then a significant saving in the reduced number of mechanical complications that would be expected to follow less frequent line insertion, providing that the procedure is still performed by experienced operators. However, the CSS and RM catheters are still quite limited in their duration of activity. The evidence of the best clinical trials to date would support a one-week duration for CSS catheters and a two-week duration for RM catheters 8, 47 . Therefore there is increasing interest in developing catheter technologies that will extend their antimicrobial activity beyond two weeks.
Recent Developments
A novel approach to extending the duration of activity is the silver iontophoretic catheter. This consists of a pair of silver wires wrapped helically around the catheter, and electrically charged by a 1.5V battery to maintain an electrical field of 20 µA 100 . The current produces a continuous release of silver ions over a prolonged period. In addition, the electrical field is believed to have a direct antimicrobial "bioelectric" effect on biofilm bacteria, as well as potentiating the action of the silver ions. The prototype catheter was tested in vitro and in an animal model and compared with the CSS catheter. The iontophoretic catheter demonstrated a comparable wide range of activity against bacteria and C. albicans and, unlike the CSS catheter, this activity was sustained for 30 days 100 .
Another approach to increasing the duration of antimicrobial activity is to have a greater depot of the effective agent by combining the agent with the catheter material, producing an impregnated rather than coated catheter. This also has the effect of ensuring that the antimicrobial is available to both internal and external surfaces. This is a feature of a new catheter that contains silver, platinum and carbon powder particles mixed throughout a polyurethane catheter ("Vantex", Baxter Healthcare, Edwards Critical-Care, Irvine, CA). The carbon makes the polyurethane electrically conductive so as to allow ongoing release of silver ions from the catheter on an electrochemical basis (MT Quinn, EL Milder; product information-Baxter). There is in vitro evidence of effective antimicrobial activity at seven days (PR Lichtenthal; product information-Baxter). However, there are no clinical trial results available at present. A similar approach of impregnating the catheter material with rifampicin and minocycline is believed to be under development (Cook, personal communication) .
CONCLUSIONS
Central venous catheter infections are a substantial and preventable cause of iatrogenic morbidity and mortality. The attributable mortality of a single episode of catheter-related bacteraemia (CRB) is between 10 to 35%, and the cost of a non-fatal episode is approximately A$50,000. Colonization (15 to 40% of CVCs) of either the external luminal surface of the catheter by organisms from the insertion site, or the internal luminal surface by organisms from the catheter hub, precedes CRB (3 to 7% of CVCs).
Catheter colonization is diagnosed by standard microbiological techniques. The diagnosis of CRB is classified as definite, probable or possible, depending upon the results of cultures from the catheter tip, the peripheral blood and other possible sites of infection. The presence of clinical symptoms is not a requirement, but can assist in making the diagnosis.
The only certain way of avoiding CRB is to avoid central venous access. The need for a CVC should always be considered on an individual patient basis. The catheter should also be removed as soon as practicable, as one of the most effective and cost-efficient ways of reducing the incidence of CRB.
The subclavian site has the lowest associated infection rate, and subcutaneous tunnelling is not required. Significant reductions in infection rates can be achieved with the use of written guidelines, clinician education, experienced operators and ade-quate numbers of skilled nursing staff. Skin preparation with 2% chlorhexidine (in alcohol) and maximal sterile barrier techniques are further effective measures for reducing CRB. Highly permeable polyurethane dressings have the same infection rates as dry gauze dressings, with a number of advantages in maintaining a secure, dry, and visible insertion site.
There is compelling evidence that the incidence of CRB increases with the duration in situ of the catheter. Somewhat unexpectedly however, there is no evidence to support the common practice of regular scheduled catheter changes in an effort to reduce the infection rate. This is consistent with external surface catheter colonization and early CRB being due to contamination of the insertion site and breaches in sterile technique during CVC insertion. Although the guide-wire exchange method of catheter replacement has a reduced rate of mechanical complications, it may be associated with an increase in CRB. Administration sets do not require replacement any more often than at 72-hour intervals, and less frequent changes may prove to be beneficial. Reduced manipulation of catheters, administration sets and IV fluids may reduce the rate of hub contamination and intraluminal colonization.
Polyurethane is the preferred polymer for catheter construction. Benzalkonium heparin bonding and attachable silver impregnated cuffs are not effective in reducing infection rates. Chlorhexidine silver sulphadiazine (CSS) coated and rifampicin minocycline (RM) coated catheters are effective in reducing colonization and CRB. A comparison of the two catheter types demonstrated reduced episodes of CRB in the second week for the RM catheters. This has been attributed to the choice of antimicrobials and the distribution of the RM coating, which covers the external and intraluminal catheter surfaces, while the CSS coating is on the external surface only. However, an alternative explanation may be that the antimicrobial action of the RM coating is sustained for up to two weeks, while that of the SSD catheter may be limited to less than one week.
Further recent innovations include increasing the quantity and duration of antimicrobial activity through impregnation of the polymer with the antimicrobial substance (cf coating), together with the use of iontophoretic techniques.
